Financial Ratios

BANDARAM PHARMA PACKTECH LTD.

NSE : NABSE : 524602ISIN CODE : INE875N01036Industry : Pharmaceuticals & DrugsHouse : Private
BSE33.091.54 (+4.88 %)
PREV CLOSE ( ) 31.55
OPEN PRICE ( ) 31.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 6742
TODAY'S LOW / HIGH ( )31.55 33.12
52 WK LOW / HIGH ( ) 2447.76
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2018Mar2017
Operational & Financial Ratios
   Earnings Per Share (Rs)0.68-0.03-0.14-5.10-4.79
   CEPS(Rs)0.24-0.01-0.02-1.72-1.66
   DPS(Rs)0.100.000.000.000.00
   Book NAV/Share(Rs)10.259.97-10.18-7.82-2.72
   Tax Rate(%)24.980.000.000.000.00
Margin Ratios
   Core EBITDA Margin(%)2.72
   EBIT Margin(%)2.70
   Pre Tax Margin(%)2.70
   PAT Margin (%)2.02
   Cash Profit Margin (%)2.04
Performance Ratios
   ROA(%)3.62-0.48-2.43-70.42-88.88
   ROE(%)6.73-3.020.000.000.00
   ROCE(%)5.21-0.940.000.000.00
   Asset Turnover(x)1.790.000.000.000.00
   Sales/Fixed Asset(x)415.390.000.000.00
   Working Capital/Sales(x)2.040.000.000.000.00
Efficiency Ratios
   Fixed Capital/Sales(x)0.00
   Receivable days97.32
   Inventory Days19.88
   Payable days21.64
Valuation Parameters
   PER(x)37.290.000.000.000.00
   PCE(x)106.290.000.00-2.74-1.71
   Price/Book(x)7.120.000.00-1.74-3.00
   Yield(%)0.140.000.00
   EV/Net Sales(x)2.60
   EV/Core EBITDA(x)95.50-91.67-281.43-3.83-1.95
   EV/EBIT(x)96.09-91.67-117.96-3.72-1.95
   EV/CE(x)3.170.312.963.211.06
   M Cap / Sales2.17
Growth Ratio
   Net Sales Growth(%)
   Core EBITDA Growth(%)2844.0024.5398.82-5.66-2141.22
   EBIT Growth(%)2827.0068.3797.26-8.59-2145.78
   PAT Growth(%)2113.0967.9197.28-6.49-2192.97
   EPS Growth(%)2113.8175.6597.28-6.49-531.41
Financial Stability Ratios
   Total Debt/Equity(x)1.430.00-0.63-0.68-1.26
   Current Ratio(x)7.27299.990.660.821.64
   Quick Ratio(x)6.57299.990.660.824.26
   Interest Cover(x)545.40-69.64-184.15-39.45
   Total Debt/Mcap(x)0.200.390.42

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.